Prior studies indicate that Cyp1a1, Cyp1a2, and Cyp2b1 are potential targets for treating of cholestasis (Ding et al., 2014; Ibrahim, 2015; Wang et al., 2022). Here, CYP1A2 is linked to cholestasis.